News

News

FDA Analysis Finds 50% Increase in 5-Year Mortality with Paclitaxel-Eluting Devices

Mar 21, 2019

After a preliminary analysis of long-term follow-up data, the FDA has found that paclitaxel-coated devices used to treat femoropopliteal artery disease are linked with up to approximately a 50% increased risk in mortality. | Read More

Dake

News

Vascular Leaders Review Mortality Outcomes, CEC, and Internal Evaluation of Drug-Eluting Devices

Mar 08, 2019

The Vascular Leaders forum 2019 featured experts who addressed questions raised by the meta-analysis of paclitaxel-eluting devices by Katsanos and colleagues. | Read More

Stethoscope

News

No Evidence for Increased Mortality With Drug-Coated Devices Observed in Medicare Database Analysis

Feb 19, 2019

After analyzing data from Centers for Medicare and Medicaid Services beneficiaries, researchers found no evidence of increased all-cause mortality for patients who underwent femoropopliteal artery revascularization with drug-coated devices compared… | Read More

News

Which Cardiovascular Risk Factors Are Linked With Venous Thromboembolism?

Feb 01, 2019

To further establish whether such an association exists, and to what extent the factors are linked, the researchers used data from several population-based cohort studies spanning decades, according to a study published in JAMA Cardiology. | Read More

News

Eximo Medical Ltd. Announces First Commercial Case of Its B-Laser™ Atherectomy System in the U.S. and Publication of Its IDE and CE Studies Results

Jan 14, 2019

Eximo Medical Ltd., announced the successful launch and first commercial use of the B-Laser™ Atherectomy System for treatment of peripheral vascular disease. | Read More

News

TEVAR Confers Greater Survival vs Medical Therapy in Uncomplicated Type B Aortic Dissection

Dec 13, 2018

Thoracic endovascular aortic repair (TEVAR) is associated with a greater survival benefit vs medical therapy in patients with uncomplicated type B aortic dissection (UTBAD), according to a new study. | Read More

embotrap

News

Cerenovus Launches Largest Global Registry to Study Stroke-Inducing Blood Clots Removed by Thrombectomy

Dec 13, 2018

CERENOVUS business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyze stroke-inducing blood clots removed from the brain with its EMBOTRAP II Revascularization Device, a next generation stent retriever… | Read More

News

BD Announces Clinical Trial Data for the LUTONIX® 014 Drug-Coated Balloon Below-The-Knee IDE Trial

Oct 22, 2018

Becton, Dickinson and Company presented safety and efficacy results of the LUTONIX® trial during a late-breaking clinical trials session at VIVA 2018. | Read More

joint-statement

News

Leading Interventional Radiology Societies Call for Expanded Stroke Training

Oct 19, 2018

Global position statement from the Society of Interventional Radiology (SIR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), and the Interventional Radiology Society of Australasia (IRSA) highlights critical needs on World… | Read More